Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer

Journal of B.U.ON.

Volumn 18, Issue 4, 2013, Pages 908-914

  Li, Tianrong ^a   Lu, Jie ^a   Zhong, Yunhua ^a  

^a FIRST PEOPLE S HOSPITAL OF YUNNAN PROVINCE   (China)

Author keywords

Cell cycle; Cell growth; COX 2; Lentivirus; NSCLC

Indexed keywords

CELECOXIB; CYCLIN D1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; LENTIVIRUS VECTOR; MESSENGER RNA; NIMESULIDE; PROTEIN P21; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SURVIVIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLOOXYGENASE 2; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LENTIVIRUS; LUNG NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84893079491     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Alam M, Wang JH, Coffey JC et al. Characterization of the effects of cyclooxygenase-2 inhibition in the regulation of apoptosis in human small and non-small cell lung cancer cell lines. Ann Surg Oncol 2007:14:2678-2684. (Pubitemid 47389557)
2. Grimes KR, Warren GW, Fang F, Xu Y, St Clair WH. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo. Oncol Rep 2006;16:771-776.
3. Dalwadi H, Krysan K, Heuze-Vourc'h N et al. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Clin Cancer Res 2005;11:7674-7682. (Pubitemid 41611609)
4. Pawliczak R, Logun C, Madara P et al. Cytosolic phospholipase A2 Group IV alpha but not secreted phospholipase A2 Group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors gamma 1 and 2 in human lung cells. J Biol Chem 2004;279:48550-48561. (Pubitemid 39625729)
5. Tong M, Ding Y, Tai HH. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells. Carcinogenesis 2006;27:2170-2179. (Pubitemid 44644805)
6. Altorki NK, Port JL, Zhang F et al. Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer. Clin Cancer Res 2005;11:4191-4197. (Pubitemid 40791585)
7. Zhao Q, Wang C, Zhu J et al. RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth, invasion and migration of SaOS2 human osteosarcoma cellsa case control study. J Exp Clin Cancer Res 2011:30:26.
8. Chuang CW, Pan MR, Hou MF, Hung WG Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Spl in breast cancer cells. J Cell Physiol 2012;228:341-348.
9. Chen CC, Cheng YY, Chen SC et al. Cyclooxygenase-2 expression is up-regulated by 2-aminobipheny1 in a ROS and MAPK-dependent signaling pathway in a bladder cancer cell line. Chem Res Toxicol 2012;25:695-705.
10. Zhong Y, Xia Z, Liu J, Lin Y, Zan H. The effects of cycloox-ygenase-2 gene silencing by siRNA on cell proliferation, cell apoptosis, cell cycle and tumorigenicity of Capan-2 human pancreatic cancer cells. Oncol Rep 2012;27:1003-1010.
11. Thiel A, Mrena J, Ristimaki A. Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev 2011;30:387-395.
12. Krysan K, Dalwadi H, Sharma S, Pold M, Dubinett S. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res 2004;64:6359-6362. (Pubitemid 39297884)
13. Byun JH, Lee MA, Roh SY et al. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer. Jpn J Clin Oncol 2006;36:263-268. (Pubitemid 43997329)
14. Hida T, Kozaki K, Muramatsu H et al. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 2000;6:2006-2011. (Pubitemid 30305099)
15. Stanojevic-Bakic N. Cyclooxygenase inhibitors in the chemoprevention of colorectal cancer. JBUON 2004;9:139-145. (Pubitemid 39149456)
16. Khuri FR, Wu H, Lee JJ et al. Cyclooxygenase-2 overex-pression is a marker of poor prognosis in stage I nonsmall cell lung cancer. Clin Cancer Res 2001;7:861-867. (Pubitemid 32708722)
17. Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 2004;96:1769-1780. (Pubitemid 39654571)
18. Wang SM, Ye M, Ni SM, Wu X, Yang G. Effect of COX-2 inhibitor on the expression of BCL-3 and cyclin Dl in human colon cancer cell line SW480. Zhonghua Wei Chang Wai Ke Za Zhi 2010;13:612-615.
19. Li W, Jiang HR, Xu XL et al. Cyclin dl expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo. Int J Mol Sci 2010;11:3999-4013.
20. Grosch S, Tegeder I, Niederberger E, Brautigam L, Geisslinger G. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J 2001;15:2742-2744.
21. Klimp AH, Hollema H, Kempinga C, van der Zee AG, de Vries EG, Daemen T. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res 2001;61:7305-7309. (Pubitemid 32946529)
22. Hosomi Y, Yokose T, Hirose Y et al. Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 2000;30:73-81.
23. Hida T, Yatabe Y, Achiwa H et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 1998;58:3761-3764.
24. Hwang D, Scollard D, Byme J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998;90:455-460. (Pubitemid 28160637)
25. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998;58:4997-5001. (Pubitemid 28521147)
26. Krysan K, Reckamp KL, Sharma S, Dubinett SM. The potential and rationale for COX-2 inhibitors in lung cancer. Anticancer Agents Med Chem 2006;6:209-220. (Pubitemid 43796639)
27. Warner TD, Mitchell JA. Cyclooxygenases:new forms, new inhibitors, and lessons from the clinic. FASEB J 2004;18:790-804. (Pubitemid 38544498)
28. Chan G, Boyle JO, Yang EK et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999;59:991-994. (Pubitemid 29135955)
29. Siegfried JM, Gubish CT, Rothstein ME, Queiroz de Oliveira PE, Stabile LP. Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer. Mol Pharmacol 2007;72:769-779. (Pubitemid 47347312)
30. Brown JR, DuBois RN. COX-2:a molecular target for colorectal cancer prevention. J Clin Oncol 2005;23:2840-2855. (Pubitemid 46179475)
31. Lee EJ, Choi EM, Kim SR et al. Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U20S human osteosarcoma cells. Exp Mol Med 2007;39:469-476.
32. Masferrer JL, Leahy KM, Koki AT et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000;60:1306-1311. (Pubitemid 30151999)
33. Souza RF, Shewmake K, Beer DG, Cryer B, Specifier SJ. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res 2000;60:5767-5772.
34. Mehar A, Macanas-Pirard P, Mizokami A, Takahashi Y, Kass GE, Coley HM. The effects of cyclooxygenase-2 expression in prostate cancer cells:modulation of response to cytotoxic agents. J Pharmacol Exp Ther 2008;324:1181-1187. (Pubitemid 351397841)
35. Wang R, Wang X, Lin F, Gao P, Dong K, Zhang HZ. shRNA-targeted cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells. Mol Cell Biochem 2008;317:179-188.
36. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of Gl cyclin-dependent kinases. Cell 1993;75:805-816. (Pubitemid 23346377)
37. el-Deiry WS, Harper JW, O'Connor PM et al. WAF 1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-1174. (Pubitemid 24108052)
38. Shoji T, Tanaka F, Takata T et al. Clinical significance of p21 expression in non-small-cell lung cancer. J Clin On-col 2002;20:3865-3871.
39. Mate JL, Ariza A, Aracil C et al. Cyclin Dl overexpression in non-small cell lung carcinoma-correlation with Ki67 labelling index and poor cytoplasmic differentiation. J Pathol 1996;180:395-399. (Pubitemid 27014077)